Squamous Cell Carcinoma Clinical Trial

By participating in a squamous cell carcinoma clinical trial, an individual can be among the first patients to receive a promising new treatment that is not yet available in other settings. The advantages of these important studies are twofold: patients can begin benefiting from breakthrough treatments as soon as possible, and researchers can assess the effectiveness of these new treatments as compared to the current standard of care. If the new treatment proves to be more effective, or equally effective with fewer side effects, it may become the new standard of care for all patients with squamous cell carcinoma.

As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt Cancer Center is leading the way in cancer research. Through extensive scientific studies and robust clinical trials, we are learning more each day about the causes, prevention and treatment of all forms of skin cancer. By participating in a squamous cell carcinoma clinical trial at Moffitt, patients can benefit from our very latest findings, such as encouraging new forms of:

• Photodynamic therapy
• Topical chemotherapy medications
• Drugs that target specific cell proteins that have been linked to squamous cell carcinoma

Clinical trial participants at Moffitt are closely monitored by a multispecialty team of experts who specialize in treating skin cancer and collaborate to develop highly individualized treatment plans. In this way, we ensure that each patient benefits from multiple expert opinions, receives the most appropriate treatments and dosages and has the support necessary to manage any side effects. Our patients also benefit from the convenience of having access to all of our treatments and supportive services in a single location without referrals.

If you are interested in participating in a squamous cell carcinoma clinical trial, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.